|1.||Shipelin, V A: 3 articles (02/2015 - 01/2012)|
|2.||Kutsenko, L A: 3 articles (01/2015 - 01/2012)|
|3.||Mamontova, T V: 3 articles (01/2015 - 01/2012)|
|4.||Bobrova, N A: 3 articles (01/2015 - 01/2012)|
|5.||Kaĭdashev, I P: 3 articles (01/2013 - 01/2012)|
|6.||Masuko, Kayo: 3 articles (01/2009 - 10/2007)|
|7.||Kato, Tomohiro: 3 articles (01/2009 - 10/2007)|
|8.||Yudoh, Kazuo: 3 articles (01/2009 - 10/2007)|
|9.||Wang, Lei: 2 articles (01/2016 - 07/2014)|
|10.||Shi, Jinjin: 2 articles (01/2016 - 07/2014)|
01/01/2009 - "The aim of this study was to examine the potential of a strong free-radical scavenger, water-soluble fullerene (C60), as a protective agent against the RANK-induced osteoclastogenesis and osteoclastic bone destruction in arthritis, both in vitro and in vivo. "
01/01/2012 - "The effect of fullerene C60 (FC60) on the immune processes during experimental adjuvant-induced arthritis (AA) in rats has been studied. "
01/01/2012 - "[Fullerene C60 exhibits immunomodulatory activity during adjuvant-induced arthritis in rats]."
01/01/2009 - "Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis."
01/01/2009 - "Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis."
05/01/2014 - "Under the conditions, the maximum intracellular uptake amount was more abundant for HT1080 cells than for DUMS16 cells, either by immunostain/fluorography using polyclonal antibody against fullerene [C60], or by HPLC method indicating the 2.4-fold preferential uptake of C60-PEG into HT1080 cells, suggested to greater phagocytotic ability characteristic of cancer cells, over DUMS16 cells being non-macrophage-like normal cells. "
12/10/2010 - "Here we show that a water-dispersed nanoparticle solution of derivatized fullerene C60, C60(Nd) nanoparticles (nC60(Nd)), has greater potential in inducing autophagy and sensitizing chemotherapeutic killing of both normal and drug-resistant cancer cells than nC60 does in an autophagy-dependent fashion. "
12/10/2010 - "The fullerene C60 nanoparticle (nC60) has been shown to induce autophagy and sensitize chemotherapeutic killing of cancer cells, but the details still remain unknown. "
11/01/2009 - "It has been reported that fullerene C60 induces certain hallmarks of autophagy in cancer cells. "
11/01/2009 - "Fullerene C60 possesses potent anti-cancer activities, but its considerable toxicity towards normal cells may hinder its practical applications. "
|3.||Lewis Lung Carcinoma
12/01/2014 - "The aim of this study was to estimate the antitumor effect and antioxidant enzyme activity of combined C60 fullerene and Dox (C60 + Dox) in the liver and heart of mice with Lewis lung carcinoma compared with Dox treatment alone. "
07/01/2015 - "The results of in vivo experiments using Lewis lung carcinoma in mice confirmed the enhancement of the Dox toxicity towards tumor cells after drug complexation with C60 fullerene. "
12/01/2015 - "The main aim of this work was to evaluate the effect of doxorubicin in complex with C60 fullerene (C60 + Dox) on the growth and metastasis of Lewis lung carcinoma in mice and to perform a primary screening of the potential mechanisms of C60 + Dox complex action. "
|4.||Body Weight (Weight, Body)
01/01/2012 - "Toxicity of fullerene C60 in male Wistar rats under conditions of a daily intragastric administration at doses of 0.1; 1 and 10 mg/kg body weight for 92 days was studied. "
02/01/2015 - "The methods of laser confocal microscopy were employed to study the changes in rat target organs (iliac mucosa and liver) provoked by peroral administration of dispersion of nanosized (31 nm) multimolecular fullerene C60 particles in doses of 0.1, 1.0, and 10 mg/kg body weight over 92 days. "
03/01/2012 - "A four-week experiment dealing with the intragastric administration of fullerene C60 dispersion to rats has established that this substance in a dose of 1 to 10 mg/kg body weight causes a number of changes in the parameters of animals, such as reductions in relative liver weight and isoform CYP 1A2 activity and increases in glutathione reductase activity, eosinophils, and neutrophils. "
|1.||Polyethylene Glycols (Polyethylene Glycol)
|2.||Folic Acid (Vitamin M)
|3.||ferric oxide (iron oxide)
|6.||Cytochrome P-450 CYP1A2 (CYP1A2)
|8.||Reactive Oxygen Species (Oxygen Radicals)
|2.||Photochemotherapy (Photodynamic Therapy)
|3.||Life Support Care
|4.||Drug Therapy (Chemotherapy)